Retina
Latest News
03.01.21
SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Advance Gene TherapiesSource: SalioGen Therapeutics
03.01.21
Bio-Tissue Receives FDA Clearance to Proceed with Clinical Study Using Investigational New Drug TTBT01Source: Bio-Tissue
03.01.21
Retinal Therapeutics Development Company Oxular Completes $37 Million (£27 million) FinancingSource: Oxular
03.01.21
Accure Therapeutics Enrolls First Patient in Phase 2 Clinical Trial on Acute Optic NeuritisSource: Accure Therapeutics
02.26.21
Envision Announces Call for Applications for Next Class of Research FellowsSource: Envision
02.25.21
Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical TestingSource: FirstWord
02.24.21
New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Beyond Acute Disease into Chronic PhaseSource: Horizon Therapeutics
02.24.21
One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report FindsSource: USA Today